John K. Wee
10 Biopolis Road, #05-01
Singapore, 138670, Singapore
Singapore, 138670, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*.
Journal: Angewandte Chemie (International ed. in English)
Published: April 20, 2021
Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2.
Journal: Journal of medicinal chemistry
Published: January 08, 2020
Correction to "Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3".
Journal: ACS medicinal chemistry letters
Published: August 16, 2019
Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3.
Journal: ACS medicinal chemistry letters
Published: April 15, 2019
Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia.
Journal: Journal of medicinal chemistry
Published: April 24, 2018
Discovery and characterisation of the automethylation properties of PRDM9.
Journal: The Biochemical journal
Published: December 06, 2016
Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 01, 2016
Structure-Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic Cells.
Journal: Journal of medicinal chemistry
Published: March 25, 2016
Identification of covalent active site inhibitors of dengue virus protease.
Journal: Drug design, development and therapy
Published: December 18, 2015
A P2 and P3 substrate specificity comparison between the Murray Valley encephalitis and West Nile virus NS2B/NS3 protease using C-terminal agmatine dipeptides.
Journal: Peptides
Published: August 31, 2013
Last Updated: 09/26/2026